京新药业(002020) - 2017 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2017 was CNY 478,411,667.28, representing a 14.61% increase compared to CNY 417,413,380.97 in the same period last year[8]. - Net profit attributable to shareholders was CNY 73,639,019.29, up 21.66% from CNY 60,528,907.37 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was CNY 63,879,366.28, reflecting a 16.10% increase from CNY 55,020,851.07 in the previous year[8]. - The basic earnings per share increased to CNY 0.1152, a rise of 21.65% compared to CNY 0.0947 in the same quarter last year[8]. - The company expects net profit attributable to shareholders for the first half of 2017 to increase by 20.00% to 30.00%, estimating between CNY 165.9751 million and CNY 179.8064 million[27]. Assets and Shareholder Equity - The total assets at the end of the reporting period were CNY 3,367,758,821.98, an increase of 2.34% from CNY 3,290,625,699.18 at the end of the previous year[8]. - The net assets attributable to shareholders increased to CNY 2,454,624,150.70, up 3.09% from CNY 2,381,007,672.23 at the end of the previous year[8]. - The number of ordinary shareholders at the end of the reporting period was 27,833[10]. Cash Flow and Operating Activities - The net cash flow from operating activities was CNY 89,451,853.07, down 17.98% from CNY 109,067,251.93 in the same period last year[8]. Investment and Income - The company reported a significant increase in investment income, which rose to CNY 8,661,856.52, a 219.01% increase compared to CNY 2,715,260.27 in the previous year[16]. - Investment income increased by CNY 5.9466 million, a growth of 219.01%, primarily due to the growth in income from bank financial products[20]. Liabilities and Expenses - The company's prepayments increased by 42.24% to CNY 21,281,807.38, primarily due to an increase in advance payments for materials[16]. - Interest receivables increased by CNY 6.513 million, a growth of 190.08%, mainly due to the increase in interest from financial products and acceptance guarantee deposits[17]. - Construction in progress decreased by CNY 27.8157 million, a decline of 30.43%, primarily due to the completion of civil engineering projects transferred to fixed assets[17]. - Employee compensation payables decreased by CNY 10.0794 million, a decline of 46.85%, mainly due to the distribution of year-end bonuses accrued at the end of the previous year[17]. - Operating taxes and surcharges increased by CNY 5.0539 million, a growth of 123.06%, mainly due to changes in accounting policies affecting property tax, land use tax, and stamp duty[17]. - Management expenses increased by CNY 22.1783 million, a growth of 42.04%, primarily due to increases in technology development costs and salary benefits[18]. - Financial expenses increased by CNY 1.6385 million, a growth of 216.73%, mainly due to increased exchange losses and decreased interest income[19].